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Edited by Felix WielandAbstract Oxysterols result from cholesterol by enzymatic or
oxidative processes. Some exert cytotoxic eﬀects leading to
necrosis or apoptosis. Detoxiﬁcation of these compounds mainly
occurs in the liver and requires transport from peripheral tissues
towards it. Some ATP-binding cassette transporters are involved
in export of cytotoxic compounds. In the current study, we inves-
tigated whether ABC transporter family member G1 (ABCG1)
may be involved in oxysterol transport, since its gene expression
is highly responsive to oxysterol loading. TetOﬀ HeLa cells
stably expressing ABCG1 showed decreased mass uptake of
7b-hydroxycholesterol (7b-HC) whereas that of other physiolog-
ically relevant oxysterols was unaﬀected. Application of 7b-HC
to ABCG1 expressing cells induced hyperpolarization of mito-
chondrial membrane potential and production of reactive oxygen
species, indicating energy consumption by the ATP-binding cas-
sette transporter when it is activated by its correct substrate. Our
study points to detoxiﬁcation as one of potential cellular func-
tions of ABCG1. We assume that ABCG1 protects against
7b-HC-induced cell death, an important role in prevention of
neurodegenerative and cardiovascular disease.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: ATP-binding cassette transporter; ABCG1;
7b-Hydroxycholesterol; Cholesterol; Substrate1. Introduction
Oxysterols are biologically active products of cholesterol
and are present at high levels in macrophages of the atheroscle-
rotic plaque or in the brain of patients with neurodegenerative
diseases [1–4]. Various oxysterols repress the pacemaker en-Abbreviations: ABC, ATP-binding cassette; ABCA1, ABC transporter
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ramethylrhodamine ethyl ester
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In addition, hydroxycholesterol (HC) derivatives oxidized in
the side chain activate the transcription factor liver-X-receptor
(LXR) [8]. Oxysterol formation occurs speciﬁcally by enzy-
matic conversion of cholesterol during bile acid and steroid
hormone synthesis (7a-HC) or when excess cholesterol in the
brain (24-HC) or in macrophages (27-HC) is targeted for ex-
port and subsequent degradation [1,2]. Contact with peroxides,
reactive nitric oxide species, or superoxide-radicals results in
non-speciﬁc oxidation of cholesterol and produces 7b-HC, 7-
ketocholesterol, 25-HC, and 5,6-epoxides as the major prod-
ucts [1,4]. HC derivatives are produced when mitochondria
hyperpolarize or peroxisomes are highly active under condi-
tions of cell stress [9,10] and show cytotoxic eﬀects. For in-
stance, 7b-HC was shown to eﬃciently induce cell apoptosis
and necrosis in U937 monocytes [11] by destabilizing mem-
branes leading to lysis of mitochondria and lysosomes
[9,12,13]. For this reason, oxysterols have to be eﬀectively re-
moved from cells, but mechanisms underlying their transport
are poorly understood.
ATP-binding cassette transporters are involved in energy
dependent translocation of various substrates including sugars,
lipids, peptides and xenobiotics across membranes [14]. Family
member 1 of the G-subgroup of mammalian ABC transporters
(ABCG1) is thought to be involved in cellular export of choles-
terol and sphingomyelin [15,16]. However, in the ABCG1 deﬁ-
cient mouse model no changes in plasma cholesterol levels
were observed [15], and a study using ABCG1-deﬁcient mice
in the homogenous genetic background of LDL-receptor deﬁ-
ciency attributed a moderately anti-atherogenic role to
ABCG1 already at relatively low plasma cholesterol levels
[17]. Another study using an independently generated
ABCG1-deﬁcient mouse model suggested involvement of
ABCG1 in the development of obesity [18].
Since ABCG1’s gene expression is highly responsive to oxy-
sterol treatment, we argued that the transporter may be in-
volved in cellular export of its inducers. In this respect, it
may have a function comparable to its family member ABCG2
which is involved in export of cytotoxic xenobiotics, e.g. used
in chemotherapy against breast cancer [19]. Other ABC trans-
porters such as multidrug resistance protein (MDR, ABCB1),
MDR-related protein 1 (MRP1, ABCC1), and the obligate
heterodimeric ABCG5/ABCG8 complex are also involved in
clearance of toxic compounds from cells [15,20,21]. Bile acids
can counteract the activation of ABCG1 gene expression in-
duced by oxysterols [22].blished by Elsevier B.V. All rights reserved.
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cell lines [16] to analyze involvement of ABCG1 in transport of
speciﬁc oxysterols. We identiﬁed a ring-substituted oxysterol
as its substrate which indicates that ABCG1 is involved in cel-
lular detoxiﬁcation rather than in cholesterol export. Our re-
sults may give new insights into prevention of pathologic
conditions involving oxysterols, namely neurodegenerative dis-
eases and atherosclerosis.2. Materials and methods
2.1. Reagents
Anti-a-tubulin antibody was obtained from Sigma–Aldrich (Deis-
enhofen, Germany), anti-heamagglutinin (HA) antibody, as well as
LXR and retinoid-X-receptor (RXR) agonists, as previously described
[16]. Avasimibe was a kind gift of Parke–Davis. Tetramethylrhod-
amine ethyl ester (TMRE) and dihydroethidium (DHE) were pur-
chased from Molecular Probes (Eugene, OR, USA). Reagents for
lipid analysis were of analytical grade and were supplied by Sigma–Al-
drich except water and organic solvents (HPLC-grade; Mallinckrodt
Baker, Griesheim, Germany).2.2. Cells
TetOﬀ-HeLa cell lines stably cotransfected with pTK-Hyg and
pTRE expression plasmids (Clontech) containing wt (clone 94) or mu-
tant (clone 47) (HA)3-ABCG1(666) [16] were maintained and used in
experiments, as previously described [16].
2.3. Western blot analysis
Samples were analyzed as previously described [16]. Filters were
cut and developed with the anti-a-tubulin antibody or the anti-
HA antibody. a-Tubulin migrated at 50 kDa, (HA)3-ABCG1 at
70 kDa.2.4. FACS measurement
In case of the TetOﬀ HeLa cell lines 1 · 105 cells were seeded per well
of a 24-well plate with 1 lg or 100 pg doxycycline per ml medium.
Thirty hours later medium was replaced with fresh medium supple-
mented with identical concentration of doxycycline plus oxysterols,
as indicated in the ﬁgure legends. Twelve hours later cells were incu-
bated with 20 nM TMRE for 20 min at room temperature, or 10 lM
DHE at 37 C for 15 min [11]. Cells were detached from the plate, pel-
leted, resuspended in PBS, and analyzed employing a FACScan ﬂow
cytometer equipped with Lysis II software (Becton-Dickinson, Heidel-
berg, FRG). Subconﬂuent RAW264.7 macrophages were seeded at a
density of 1.5 · 105 cells per well in complete medium with or without
1 lM LXR and 0.1 lM RXR agonists. After 24 h medium was re-
placed with DMEM supplemented with antibiotics, with or without
LXR and RXR agonists, respectively, 0.2% bovine serum albumin,
5 lM acyl-CoA acyl transferase (ACAT) inhibitor avasimibe and
increasing concentration of 7b-HC. After 24 h cells were analyzed
for TMRE ﬂuorescence, as describe above for the HeLa cells.
Cells within the TMRE negative region were regarded as dead,
those in the TMRE-positive region as live. Triplicate samples were
analyzed.2.5. Quantitative RT-PCR measurement
HeLa cells (3 · 106) were seeded in 6 cm petri dishes in complete
medium supplemented with the respective concentration of doxycy-
cline. Twenty-four hours later medium was replaced with fresh one
plus the respective concentration of doxycycline and cells were incu-
bated for further 16 h. Cells were harvested, RNA was extracted, re-
verse transcribed, and quantitative PCR was performed as previously
described [23] except SuperScriptIII (Invitrogen, Karlsruhe, FRG)
was used. Primers for detection of endogenous and exogenous ABCG1
at the same time were: 5 0-CTG GCT GGA TAC AGG GAG AC-3 0;
5 0-CCT GCA TGA TGT AGC AGG AC-3 0; those for mouse ABCG1
transcript: 5 0-CAC GCA AGT CTG ACG ATG AC-3 0; 5 0-CCA ACC
GTC CTA CAT CTT CC-3 0.2.6. Preparation of lipid emulsion
Fifty milligrams of egg yolk phosphatidylcholine (PC) in chloroform
(Sigma) and 50 lg of individual oxysterol, respectively, in methanol
were mixed together in a conical glass tube. Solvent was evaporated
under a stream of nitrogen gas and 25 ml of DMEM was added. Mix-
ture was vigorously vortexed and subsequently sonicated with a Sono-
puls GM70 (Bandelin electronic, Berlin, FRG) until a transluscent
solution was obtained. Emulsion was centrifuged for 5 min at
580 · g and supernatant fraction supplemented with 0.1% bovine ser-
um albumin was used in the experiment.
2.7. Lipid analysis
Cells (3 · 106 ) were seeded in 6 cm petri dishes in complete medium
supplemented with the respective concentration of doxycycline. After
24 h complete medium was replaced and supplemented again with
fresh doxycycline. Sixteen hours later cells were washed twice with
DMEM/PSG and were incubated in DMEM/PSG for 30 min at
37 C. Medium was replaced with 5 ml lipid emulsion plus doxycycline
and cells were incubated for 4 h. Cells were washed twice with DMEM/
PSG and incubated for 30 min in DMEM/PSG. Cells were washed and
scraped oﬀ the plate in PBS/0.1% EDTA and harvested by centrifuga-
tion. Cell pellet was resuspended in 1.3 ml distilled water and sonicated
for 10 s (Sonopuls GM70, as above). Protein content was measured
using the BCA protein assay (Pierce, Rockford, IL; USA). Cholesterol
determination was performed as described previously employing a
100 ll aliquot of the sample [23].
For oxysterol measurement as an internal standard and anti-oxidant
reagent a methanolic solution of 1 ng/ll 22S-HC with 20 ng/ll 3,5-di-
tert-butyl-4-hydroxytoluol (BHT) was used. Four hundred microliters
of this solution were added to 1 ml of cell homogenate and subjected to
saponiﬁcation with 2 ml of 20% tetramethyl-ammoniumhydroxide/2-
propanol (w/v, 30 min, 80 C). Three milliliters of water were added
to the cold sample followed by twice extraction with 4 ml of n-hexane.
The upper layers were combined in a silanized glass tube and the or-
ganic solvent was removed under a steam of nitrogen. The residue
was resolved in 100 ll of HPLC eluent (solvent system 2-propanol/n-
heptane/acetonitrile, 35:12:52, v/v/v). To remove cholesterol the sample
was subjected to HPLC-fractionation (conditions described previously
but with a 100 ll loop injector) [24]. Oxysterols were collected in silan-
ized glass tubes within the 3rd and 6th minute after HPLC-injection
(fractionating apparatus: Advantec SF2120), derivatized [24], and sub-
jected to further analysis by gas chromatography–mass spectrometry
(GC–MS).
GC–MS analysis of sterols was performed on a GCQ system (Ther-
mo-Finnigan, Bremen, Germany) equipped with an ion trap mass ana-
lyzer and a HT-5 fused silica capillary column (SGE, Darmstadt,
Germany; 25 m, inner diameter 0.22 mm, ﬁlm thickness 0.1 lm).
Twenty microliters of the sample were injected in large volume solvent
split mode at 55 C and vaporized splitless at 280 C. Helium was used
as carrier gas at a constant velocity of 30 cm/s. The temperature of the
column oven was maintained at 50 C for 4 min, increased with 25 C/
min to 200 C and ﬁnally increased with 10 C/min to 280 C. The
parameters for the ion trap mass analyzer were as follows: transfer line
at 280 C, positive electron ionization mode (70 eV), ion source at
180 C, full scan on masses 50–650 Da. Oxysterol compound concen-
trations were quantiﬁed by comparing the ion current response of
the sum of characteristic quantitation masses with the peak area re-
sponse obtained for the known amount of the added internal standard.
Amounts of oxysterol were normalized to the protein content. Dupli-
cate samples were analyzed.3. Results
In order to identify whether ABCG1 is able to transport
oxysterols we used our previously characterized TetOﬀ HeLa
cell lines which allow regulatable expression of ABCG1(666)
or the ABCG1(666,K124M) defective mutant [16] over four
orders of magnitude. Oxysterols were applied as an emulsion
of 0.1% (w/w) oxysterol/phosphatidylcholine for 4 h, which
protected the cells from destructive unspeciﬁc eﬀects of oxys-
terols and allowed to analyze their cellular uptake and export
Fig. 1. ABCG1 expression does not interfere with uptake of side chain oxidized HC derivatives, inducers of endogenous ABCG1 gene expression,
but prevents uptake of 7b-HC. (A) TetOﬀ HeLa cells expressing variable amounts of human ABCG1 by application of increasing doxycycline
concentrations were incubated with a PC emulsion supplemented with 24-HC (upper left panel), 25-HC (upper right panel), and 27-HC (lower left
panel) for 4 h. Subsequently the cells were analyzed for cholesterol (lower right panel) and oxysterol content, as described in Section 2. (B) TetOﬀ
HeLa cells expressing variable amounts of wt (closed boxes, straight lines) or mutant (open circles, dotted lines) form of ABCG1 by application of
increasing doxycycline concentrations were incubated with a PC emulsion supplemented with 7a-HC (upper left panel), 7b-HC (lower left panel), and
25-HC (upper right panel) for 4 h. Subsequently the cells were analyzed for cholesterol (lower right panel) and oxysterol content, as described in
Section 2.
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Fig. 2. Doxycycline dependent gene regulation in ABCG1 expressing
TetOﬀ HeLa cells. Expression of diﬀerent genes was measured by
reverse transcriptase quantitative PCR in TetOﬀ HeLa cells expressing
variable amounts of wt ABCG1 by application of increasing amounts
of doxycycline, as described in Section 2. Results are normalized to the
expression level at 1 lg/ml doxycycline. Relative expression levels for
total ABCG1 transcripts (endogenous and expressed; upper panel),
endogenous ABCG1 transcripts (2nd panel), and ABCA1 transcripts
(3rd panel) are shown. Recombinant ABCG1 protein levels within the
same cells detected with an anti-HA antibody are shown in the lower
panel, a-tubulin serves as a loading control. Duplicate samples were
analyzed.
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the substrate should be actively expelled from the cells as soon
as it enters them and, consequently, cellular uptake of the lipid
should be diminished in response to increased expression of the
transporter at low doses of doxycycline. As shown in Fig. 1A,
uptake of none of the classical LXR-agonists, the side chain
oxidized 24-HC, 25-HC, and 27-HC, was reduced. In a marked
contrast, uptake of ring oxidized 7b-HC but not its stereoiso-
mer 7a-HC was inhibited, as shown in Fig. 1B. Under the used
experimental conditions no change in cellular cholesterol con-
tent was observed (Fig. 1A and B). Uptake inhibition of 7b-
HC occurred already at an ABCG1 transcription level approx.
10-fold lower (Fig. 2) than required for radioactive cholesterol
transport measured previously in this cell line [16]. The dose re-
sponse curve for 7b-HC uptake was sigmoidal, a characteristic
feature of saturable processes (Fig. 1B).
Quantitative RT-PCR showed that the decrease of 7b-HC
uptake was inversely related to the expression of total ABCG1
transcripts, as shown in Fig. 2. As soon as the expression level
of the exogenous ABCG1 transcript exceeds that of the endog-
enous one, below a doxycycline concentration of 1 ng/ml, 7b-
HC mass uptake is decreased (compare with Fig. 1B). ABC
transporter family member A1 (ABCA1) and endogenous
ABCG1 expression levels decreased signiﬁcantly below
100 pg/ml doxycycline. The maximally achieved expression le-
vel of total ABCG1 within the wt ABCG1 expressing cell line
was 5.6(±0.4)-fold above the level of endogenous gene expres-
sion after maximal stimulation with synthetic agonists speciﬁc
for transcription factors LXR and RXR (Fig. 3).
In order to evaluate whether decreased uptake of 7b-HC de-
pended on the interaction of the oxysterol with ABCG1, we
incubated wt and mutant ABCG1 expressing cell lines with
individual oxysterols, respectively, and measured ATP con-
sumption by detecting mitochondrial membrane potential withFig. 3. Liver-X-receptor and retinoid-X-receptor dependent gene
regulation in ABCG1 expressing TetOﬀ HeLa cells. Expression of
ABCA1 (white bars) and total ABCG1 (black bars) transcripts was
measured by reverse transcriptase quantitative PCR in TetOﬀ HeLa
cells expressing wt ABCG1, as described in Section 2. ABCG1
expression was turned oﬀ by application of 1 lg/ml doxycycline (+
doxycycline) or induced by omitting doxycycline ( doxycycline).
Before harvesting the cells synthetic agonists speciﬁc for liver-X-
receptor and retinoid-X-receptor (1 lM and 0.1 lM, respectively) were
added for 24 h simultaneously to doxycycline, as indicated. Duplicate
samples were analyzed.
Fig. 4. ABCG1 expression triggers mitochondrial hyperpolarization in the presence of 7b-HC. (A) TetOﬀ HeLa cell lines expressing (black) or not
expressing (gray) wt (straight) or mutant (dotted/dashed) form of ABCG1, were incubated with 20 lg of either 7b-HC (2nd panel), 7a-HC (3rd
panel), cholesterol (4th panel), 7-ketocholesterol (5th panel), or 22S-HC (last panel), or no sterol (1st panel) for 12 h. TMRE ﬂuorescence was
recorded, as described in Section 2. (B) Amounts of cells after treatment with 7b-HC present within the region M1 (black bars) and M2 (white bars),
as indicated in the 2nd panel of (A), are shown. Triplicate samples were analyzed.
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hyperpolarization of the mitochondrial membrane potential,indicative of pronounced energy consumption when the ABC
transporter exports its correct substrate out of the cell by
Fig. 5. ABCG1 expression induces oxidative stress in the presence of 7b-HC. (A) TetOﬀ HeLa cell lines expressing (black) or not expressing (gray) wt
(straight) or mutant (dotted/dashed) form of ABCG1 were incubated with 20 lg 7b-HC (middle panel), with 20 lg 7-ketocholesterol (lower panel), or
without oxysterol (upper panel) for 12 h. Fluorescence of oxidized DHE was recorded, as described in Section 2. (B) Amounts of cells after treatment
with 7b-HC present within the region M1 (black bars) and M2 (white bars), as indicated in the middle panel of (A), are shown. Triplicate samples
were analyzed.
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As shown in Fig. 5, mitochondrial hyperpolarization was
accompanied by generation of reactive oxygen species in a spe-
ciﬁc manner only if 7b-HC was applied and expression of wt
ABCG1 was induced.
Next, we analyzed whether ABCG1 expression protects
against 7b-HC-induced cell death. As due to low p53 tumor
suppressor content as a consequence of interference with pap-
illoma virus E6 protein HeLa cells may respond incorrectly to
induction of cell death, and as ABCG1 seems to be very
important for macrophages, since it is highly expressed inthese cells [15], we used a macrophage cell line. Macrophages
are involved in clearance of dead and apoptotic cells and recy-
cling of lipids. As a consequence they are exposed to huge
amounts of oxysterols and may require an eﬃcient export of
these compounds. ABCG1 expression can be induced approx.
10-fold in RAW264.7 macrophages by application of syn-
thetic LXR and RXR agonists (Fig. 6). This treatment pro-
tects the cells against cell death induced by 7b-HC up to a
concentration of 500 ng oxysterol/ml (Fig. 6). By contrast, un-
treated macrophages die proportionally to increasing 7b-HC
concentration.
Fig. 6. Induction of ABCG1 expression prevents 7b-HC mediated
macrophage cell death. RAW264.7 macrophages were treated with
(squares) or without (circles) LXR and RXR agonists and increasing
concentration of 7b-HC for 24 h and TMRE ﬂuorescence was
recorded, as described in Section 2. Live cells, ﬁlled symbols; dead
cells, open symbols. 20000 cells were counted. Inset shows macrophage
ABCG1 transcript level with or without LXR and RXR agonist
treatment for 24 h relative to untreated cells.
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Our presented results show that ABCG1(666) is a functional
ABC transporter which is involved in transport of 7b-HC. We
could demonstrate by direct mass analysis in the absence of
isotopic labeling, which may give false results due to conver-
sion/oxidation of the radiolabeled compounds during the time
scale of the experiment, that uptake of this oxysterol is inhib-
ited by ABCG1 expression. In addition, we have shown that
combination of ABCG1 and its substrate, 7b-HC, but not cho-
lesterol, cause massive ATP consumption, implying activation
of the transporter in the presence of this oxysterol. Similar
burst of energy expenditure has been observed in cells over-
expressing ABC-transporter MDR1 following to stimulation
with chemotherapeutic drugs [25–27]. We assume that both
molecules, ABCG1 and 7b-HC, ﬁt together like key and lock,
which is contradictory to the previous assumption that choles-
terol is the substrate for ABCG1 [15,16]. In our study, the cel-
lular cholesterol content did not decrease, as would be
expected when ABCG1 is overexpressed and cholesterol is ex-
ported. It cannot be excluded that the transporter’s aﬃnity for
cholesterol is too low to result in eﬃcient cholesterol export at
the relatively low ABCG1 expression levels employed in our
study. Another plausible explanation for increased cholesterol
export by very high level ABCG1 expression is that cholesterol
homeostasis is aﬀected by cellular depletion of 7b-HC. For
instance, 7b-HC already at very low doses inhibits HMGCoA-
reductase [7]. Removal of an inhibitor would result in over-
production of cholesterol biosynthesis and subsequently
cholesterol export and cholesterol ester storage should be
observed, as was reported in BHK cells overexpressing
ABCG1 [15]. Side chain oxidized sterols have the same inhib-
itory eﬀect on HMGCoA-reductase [6], but unfortunately no
data exist comparing the eﬃciency of inhibition of 7b-HC
versus side chain oxidized sterols side by side. It is possible that
7b-HC may act as ligand for transcription factors or repressors
but such a role has not yet been clariﬁed.
Cholesterol and 7b-HC both have a planar constitution of
the cholestane ring structure but have diﬀerent polarity. The
7b-hydroxyl group causes a shift in orientation within themembranes which may be the major cause for increased mem-
brane permeability and subsequent cytotoxicity associated
with 7b-HC [28,29]. Consistent with our results, no activation
of the ABCG1 ATPase activity was observed by non-oxidized
sterols in a study performed by Cserepes and colleagues [30].
In conventional tissue culture samples the amounts of oxys-
terols present are relatively low, requiring enrichment of oxys-
terols from exogenous sources for successful quantiﬁcation by
the methodology used within this study. However, high oxy-
sterol levels may occur under chronic pathologic conditions like
those observed in the atherosclerotic plaque or in neurodegen-
erative diseases [3,31]. For instance b-amyloid and amyloid pre-
cursor protein are highly expressed in Alzheimer’s disease and
can produce 7b-HC [32]. Our uptake scenario is well tolerated
by the cells because we deliver exogenously supplied oxysterols
as a dilute mixture within a large excess of lecithin emulsion
which diﬀers extensively from conditions which have been used
to study the inﬂuence of oxysterols on phase transitions in bio-
logical membranes in vitro [29]. Incubation with the lipid emul-
sion enables both uptake and intracellular delivery of
oxysterols and at the same time allows analysis of the steady
state level inﬂuenced by the amount of expressed active trans-
porter. Consistent with our results on oxysterol uptake, it was
previously shown that even phospholipid vesicles can take up
radiolabeled cholesterol from ABCG1 overexpressing cells [33].
The moderate accumulation of 27-HC levels at high level
ABCG1 expression observed in Fig. 1A likely reﬂects the
repression of the expression of ABCA1 (Fig. 2) which was
attributed a role in the export of the side chain substituted
HC derivatives 27-HC, 24-HC, and 25-HC [34].
Application of LXR and RXR agonists to macrophages in-
duces gene expression of ABCG1 and other genes. In the con-
text of all results of our study we assume that the protective
eﬀect of agonist treatment against 7b-HC cytotoxicity, as
shown in Fig. 6, is due to the enhanced ABCG1 expression.
Consistent with our assumption, an enhanced rate of macro-
phage apoptosis in the ABCG1 deﬁcient mouse model was dis-
cussed to explain the phenotype of enhanced early onset
atherosclerotic lesion development and deposition of lipid
ﬁlled alveolar macrophages in the lung of these animals, where
lipid oxidation likely occurs at an enhanced rate due to exten-
sive exposure to atmospheric oxygen [15,17].
As ABCG1-deﬁciency may be expected to decrease 7b-HC
export capacity, 7b-HC levels should increase over time in
ABCG1-deﬁcient pneumocytes and alveolar macrophages
leading to apoptosis and subsequent lipid deposition in the
subpleural region of the lung, a process that resembles parallels
to the formation of the lipid-ﬁlled core of the atherosclerotic
plaque. Actually, increased amount of apoptotic macrophages
was observed in the vessel wall of LDL-receptor-deﬁcient mice
transplanted with ABCG1-deﬁcient bone marrow fed a high
fat/high cholesterol diet [35], which corroborates well with re-
sults of the present study.
We assume that ABCG1 is a protective factor against 7b-
HC-induced cell death. Whether it protects against apoptosis
or necrosis needs to be evaluated in a separate study. Once
the oxysterol is exported from the cell it is probably taken
up by lipoproteins where it in a ﬁrst step is detoxiﬁed by ester-
iﬁcation mediated by LCAT [36]. Lipoproteins are then cleared
from the circulation by the liver and after lysosomal liberation
of the oxysterol cytochrome-P450 containing oxidases form
7b-substituted bile acids which may leave the body via the
1680 T. Engel et al. / FEBS Letters 581 (2007) 1673–1680gut [37]. ABCG1 may thus be involved in ‘reverse transport’ of
7b-HC. This newly deﬁned activity of ABCG1 could play an
important role in prevention of oxysterol-induced cell death
in the atherosclerotic plaque, in Alzheimer’s diseased brain
cells, and in alveolar macrophages.
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